RGI-3600

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameRGI-3600
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesREGiMMUNE Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesREGiMMUNE Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A